Poolbeg Pharma identifies new flu drug targets using AIVish Gainon June 29, 2023 at 14:51 Silicon RepublicSilicon Republic
Using an AI platform developed by CytoReason, London-headquartered Poolbeg Pharma has been analysing flu human challenge trials data since March 2022.
Read more: Poolbeg Pharma identifies new flu drug targets using AI